BMC Cancer (Sep 2007)

Over-expression of 14-3-3zeta is an early event in oral cancer

  • Gupta Siddhartha D,
  • Duggal Ritu,
  • Bahadur Sudhir,
  • Matta Ajay,
  • Ralhan Ranju

DOI
https://doi.org/10.1186/1471-2407-7-169
Journal volume & issue
Vol. 7, no. 1
p. 169

Abstract

Read online

Abstract Background The functional and clinical significance of 14-3-3 proteins in human cancers remain largely undetermined. Earlier, we have reported differential expression of 14-3-3ζ mRNA in oral squamous cell carcinoma (OSCC) by differential display. Methods The clinical relevance of 14-3-3ζ protein in oral tumorigenesis was determined by immunohistochemistry in paraffin embedded sections of oral pre-malignant lesions (OPLs), OSCCs and histologically normal oral tissues and corroborated by Western Blotting. Co-immunoprecipitation assays were carried out to determine its association with NFκB, β-catenin and Bcl-2. Results Intense immunostaining of 14-3-3ζ protein was observed in 61/89 (69%) OPLs and 95/120 (79%) OSCCs. Immunohistochemistry showed significant increase in expression of 14-3-3ζ protein from normal mucosa to OPLs to OSCCs (ptrend Conclusion Our findings suggest that over-expression of 14-3-3ζ is an early event in oral tumorigenesis and may have an important role in its development and progression. Thus, 14-3-3ζ may serve as an important molecular target for designing novel therapy for oral cancer.